Literature DB >> 61490

Bromocriptine in Nelson's syndrome and Cushing's disease.

S W Lamberts, J C Birkenhäger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 61490     DOI： 10.1016/s0140-6736(76)90656-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  11 in total

1.  Pituitary-dependent Cushing's disease.

Authors:  S P Deacon
Journal:  Br Med J       Date:  1977-05-28

Review 2.  The Treatment of Cushing's Disease.

Authors:  Rosario Pivonello; Monica De Leo; Alessia Cozzolino; Annamaria Colao
Journal:  Endocr Rev       Date:  2015-06-11       Impact factor: 19.871

3.  Complete remission of Nelson's syndrome after 1-year treatment with cabergoline.

Authors:  R Pivonello; A Faggiano; F Di Salle; M Filippella; G Lombardi; A Colao
Journal:  J Endocrinol Invest       Date:  1999-12       Impact factor: 4.256

Review 4.  Pharmacology of bromocriptine in health and disease.

Authors:  A E Mehta; G Tolis
Journal:  Drugs       Date:  1979-05       Impact factor: 9.546

5.  Effectiveness of cabergoline in monotherapy and combined with ketoconazole in the management of Cushing's disease.

Authors:  Lucio Vilar; Luciana A Naves; Monalisa F Azevedo; Maria Juliana Arruda; Carla M Arahata; Lidiane Moura E Silva; Rodrigo Agra; Lisete Pontes; Larissa Montenegro; José Luciano Albuquerque; Viviane Canadas
Journal:  Pituitary       Date:  2010-06       Impact factor: 4.107

6.  Direct effects of thyrotropin-releasing hormone, cyproheptadine, and dopamine on adrenocorticotropin secretion from human corticotroph adenoma cells in vitro.

Authors:  M Ishibashi; T Yamaji
Journal:  J Clin Invest       Date:  1981-10       Impact factor: 14.808

7.  Effects of bromocriptine on pituitary tumour size.

Authors:  A M McGregor; M F Scanlon; R Hall; K Hall
Journal:  Br Med J       Date:  1979-09-22

Review 8.  The endocrine profile of bromocriptine: its application in endocrine diseases.

Authors:  I Lancranjan
Journal:  J Neural Transm       Date:  1981       Impact factor: 3.575

9.  Management Strategies for Aggressive Cushing's Syndrome: From Macroadenomas to Ectopics.

Authors:  Carlotta Pozza; Chiara Graziadio; Elisa Giannetta; Andrea Lenzi; Andrea M Isidori
Journal:  J Oncol       Date:  2012-08-09       Impact factor: 4.375

10.  A prospective longitudinal study of Pasireotide in Nelson's syndrome.

Authors:  Eleni Daniel; Miguel Debono; Sharon Caunt; Constantine Girio-Fragkoulakis; Stephen J Walters; Scott A Akker; Ashley B Grossman; Peter J Trainer; John Newell-Price
Journal:  Pituitary       Date:  2018-06       Impact factor: 4.107
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.